Mon, Mar 2, 2015, 1:08 AM EST - U.S. Markets open in 8 hrs 22 mins


% | $
Quotes you view appear here for quick access.

Antares Pharma Inc. Message Board

  • jrdelane jrdelane Feb 17, 2013 1:04 AM Flag

    The Golden Cross vs. the Death Cross

    Biotech stocks are driven by news catalysts--trial updates, FDA announcements, earnings reports, new finance offerings, partnerships, buyouts, etc. how big a role do technicals play then, when your biotech stock is about to experience a very significant chart event? I own shares of two very good biotechs that have these significant Cross events right now. APPY just experienced a golden cross on Wednesday, where the 50-day MA crossed up and over the 200-day moving average. Friday a new up leg appears to have begun. ATRS on the other hand, is poised to experience a Death Cross early next week IF there is further weakness in the stock. Look at the chart, verify this for yourself. I don't want this to happen, I own 12,000 shares, but we need some positive PR on Monday or I fear the black boxes in the trading rooms are going to unleash a fury of selling pressure on all us faithful longs. My Refuse to Lose post perhaps should read Refuse to Lose More! I am going to decide Monday if I stay or leave depending on price action and/or news. I hesitated to post this at all because it has bearish implications. But for some, it could be a prudent and timely warning to prevent further carnage. GLTA!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.61-0.04(-1.51%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.